Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

OncoMed Pharmaceuticals Inc Announces Pricing of Initial Public Offering


Wednesday, 17 Jul 2013 08:00pm EDT 

OncoMed Pharmaceuticals Inc announced the pricing of its initial public offering of 4,800,000 shares of its common stock at a price to the public of $17.00 per share. The shares are expected to begin trading on The NASDAQ Global Select Market on July 18, 2013 under the ticker symbol "OMED." All of the shares of common stock are being offered by OncoMed. In addition, OncoMed has granted the underwriters a 30-day option to purchase up to an additional 720,000 shares of common stock. Jefferies LLC and Leerink Swann are acting as joint book-running managers for the offering. Piper Jaffray and BMO Capital Markets are acting as co-managers. 

Related Company News

Company Quote

19.03
0.02 +0.11%
20 Aug 2014